AEOLUS PHARMACEUTICALS, INC.
company.status.inactiveCIK 1261734fmd_0F3MSG22QFSWT33916VJMQJ9AHManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2009 to Jun 30, 2017, 30 periods
Latest annual · FY2015
Millions- Total revenues
- 3
- Operating income
- (3)
- Net income
- (4)
Latest quarter · Q3 FY2017
Millions- Operating income
- (1)
- Net income
- (1)
Key stats
Open AnalysisCompound annual growth
- Revenue, 3 yearsFY2012 to FY2015
- -24.7%
- Net income, 5 yearsFY2011 to FY2016
- n/m
AEOLUS PHARMACEUTICALS, INC. financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2016 | FY2015 | Change | Source |
|---|---|---|---|---|
| Operating income | -$3.3 million | -$2.6 million | 10-K 2016-12-20 · proof | |
| Net income | -$3.6 million | -$2.6 million | 10-K 2016-12-20 · proof | |
| Cash from operating activities | -$3.1 million | -$2.4 million | 10-K 2016-12-20 · proof | |
| Total assets | $4.2 million | $1.8 million | +134.5% | 10-K 2016-12-20 · proof |
| Total liabilities | $972,000 | $2.6 million | -62.9% | 10-K 2016-12-20 · proof |
| Cash and cash equivalents | $3.2 million | $94,000 | +3,256.4% | 10-K 2016-12-20 · proof |
- What was AEOLUS PHARMACEUTICALS, INC.'s operating income in fiscal 2016?
- AEOLUS PHARMACEUTICALS, INC. reported operating income of -$3.3 million for fiscal 2016 (the year ended Sep 30, 2016), against -$2.6 million the year before. Source: the 10-K filed with the SEC on Dec 20, 2016. SEC
- What was AEOLUS PHARMACEUTICALS, INC.'s net income in fiscal 2016?
- AEOLUS PHARMACEUTICALS, INC. reported net income of -$3.6 million for fiscal 2016 (the year ended Sep 30, 2016), against -$2.6 million the year before. Source: the 10-K filed with the SEC on Dec 20, 2016. SEC
- What was AEOLUS PHARMACEUTICALS, INC.'s cash from operating activities in fiscal 2016?
- AEOLUS PHARMACEUTICALS, INC. reported cash from operating activities of -$3.1 million for fiscal 2016 (the year ended Sep 30, 2016), against -$2.4 million the year before. Source: the 10-K filed with the SEC on Dec 20, 2016. SEC
- What are AEOLUS PHARMACEUTICALS, INC.'s total assets?
- As of Sep 30, 2016, AEOLUS PHARMACEUTICALS, INC. reported total assets of $4.2 million, against $1.8 million a year earlier (+134.5%). Source: the 10-K filed with the SEC on Dec 20, 2016. SEC
- What are AEOLUS PHARMACEUTICALS, INC.'s total liabilities?
- As of Sep 30, 2016, AEOLUS PHARMACEUTICALS, INC. reported total liabilities of $972,000, against $2.6 million a year earlier (-62.9%). Source: the 10-K filed with the SEC on Dec 20, 2016. SEC
- What are AEOLUS PHARMACEUTICALS, INC.'s cash and cash equivalents?
- As of Sep 30, 2016, AEOLUS PHARMACEUTICALS, INC. reported cash and cash equivalents of $3.2 million, against $94,000 a year earlier (+3,256.4%). Source: the 10-K filed with the SEC on Dec 20, 2016. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1261734&period_type=annual&limit=5"Information only, not investment advice.